therapy for cancerImage Credit source: Getty images
Australian scientists have achieved great success in the treatment of myelofibrosis, a serious and rare blood cancer disease. Till now, medicines used to treat myelofibrosis only controlled the symptoms, this disease could not be completely eradicated. But now scientists at the South Australian Health and Medical Research Institute have developed a new targeted immunotherapy, which is expected to cure this disease in the future.
The research that has been done regarding new therapy. This research has been published in the prestigious medical journal Blood. According to scientists, myelofibrosis blood cancer It is a type of which is a fatal disease. Due to this, the ability to produce red blood cells in the body starts decreasing. Due to this, patients continue to suffer from problems like constant fatigue and pain in bones. In this situation, the disease is controlled only with medicines, but it is not completely eradicated. Even if the patient survives in this disease, medicines are taken throughout his life. If this cancer is detected late then it becomes difficult to save the life of the patient.
No side effects were seen on patients
Through research, scientists studied the cells of 5 thousand patients and identified two special targets through which only the disease-causing cells can be destroyed, there is no effect on the good cells. Due to this, there are no side effects of this therapy in the patient and only dangerous cells are eliminated.
According to Professor Daniel Thomas, Director of the Blood Cancer Program of the South Australian Health and Medical Research Institute, the current treatments are only able to reduce the symptoms of this disease, but till date there is no cure to completely eradicate it. But our research has shown that only cancer cells can be destroyed with special precision immunotherapy and their growth can be completely stopped.
This therapy was used
The power of precision immunology has been revealed in this study. In this technique, the body’s immune system is trained in such a way that it destroys only cancer cells. Right now this research is very promising, but scientists say that more clinical research and trials will be needed before implementing it on patients. If this method is successful, it could prove to be a major victory in the treatment of blood cancers like myelofibrosis.